U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: February 5-11, 2023
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: February 5-11, 2023

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 02/07/2023
Location: Silver Spring, MD
Subject: Evidence-Driven Disease Drug Development
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Edward Neilan, Heidi Ross, Karin Hoelzer, Pamela Gavin, Peter Saltonstall (National Organization for Rare Disorders);

Event Date: 02/10/2023
Location: Virtual
Subject: Powdered Infant Formula Safety Strategy
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: David Norr, Jena Rostorfer, Monica Wilkins, Remco Van Der Leee (Abbott Nutrition);

Event Date: 02/10/2023
Location: Virtual
Subject: Alliance for a Stronger FDA Webinar; FDA Priorities and Resource Needs, 2023 and Beyond
FDA Participant/Group: JULIA TIERNEY; DAYLE CRISTINZIO; MICHAEL FELBERBAUM;
Non FDA Participant/Group: Industry, media, and other registered attendees

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 02/06/2023
Location: Virtual
Subject: Leafy Green Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Leafy Greens Safety Coalition

Event Date: 02/07/2023
Location: Virtual
Subject: Food Safety Culture Webinar
FDA Participant/Group: N/A
Non FDA Participant/Group: Several hundred state and local retail and manufactured food-focused inspectors

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

Event Date: 02/07/2023
Location: Virtual
Subject: ORA-Biologics Roundtable Debrief
FDA Participant/Group: BRITTANY SHELTON; SARAH CLARK LYNN; ELIZABETH MILLER;
Non FDA Participant/Group: Members of the Reagan Udall Foundation

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 02/07/2023
Location: Virtual
Subject: Immuno-Oncology 360° 9th Annual Conference; Recent Regulatory Developments for CAR-T Cells
FDA Participant/Group: N/A
Non FDA Participant/Group: Science, clinical, and industry stakeholders

Event Date: 02/08/2023
Location: Virtual
Subject: Maryland BioNetworking Summit; Advancing Cell and Gene Therapy to the Next Level
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, government, and industry stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 02/09/2023
Location: Virtual
Subject: Stanford Byers Center for Biodesign
FDA Participant/Group: WILLIAM MAISEL; DOUGLAS KELLY;
Non FDA Participant/Group: James Wall, Jill Hann, Josh Makower, Kavita Patel, Lyn Denend, Sandra Ruggles (Stanford);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 02/07/2023
Location: Washington, DC
Subject: Impacts of Food Policies
FDA Participant/Group: ROBIN MCKINNON; ADAM FRIEDLANDER;
Non FDA Participant/Group: Members of the Institute for Food Technology (IFT)

Event Date: 02/09/2023
Location: Virtual
Subject: FDA / NIH Joint Public Meeting: Bridging the Biological and Communication Sciences on Nutrients and Environmental Contaminants in Foods to Support Child Development
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 02/10/2023
Location: Virtual
Subject: Front of Package Labeling (FOP)
FDA Participant/Group: EMILY ROSE CAREY; MEGAN VELEZ; WILLIAM HUBBARD; LAUREN BAHAM; LINDA VERRILL; DOUGLAS BALENTINE; ROBIN MCKINNON;
Non FDA Participant/Group: Jared Rothstein, Megan Kastner, Roberta Wagner, Sarah Brandmeier, Sarah Gallo (Consumers Brand Association);

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 02/07/2023
Location: Virtual
Subject: Prosecutorial Remedies and Other Tools to end the Exploitation of Children Today (PROTECT) Act and Cessation Care Package
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patrick Koetzle (Office of Representative Deborah Wasserman Schultz (D-FL));

Event Date: 02/09/2023
Location: Virtual
Subject: FDA Tobacco Programmatic Updates
FDA Participant/Group: Several FDA Staff
Non FDA Participant/Group: Several representatives from the U.S. House of Representatives’ Energy and Commerce Committee

Event Date: 02/10/2023
Location: Silver Spring, MD
Subject: FDA Tobacco Programmatic Updates
FDA Participant/Group: BRIAN KING; MICHELE MITAL;
Non FDA Participant/Group: Desmond Jenson (Public Health Law Center);

Official Name: Tracey H. Forfa, J.D., Acting Director, Center for Veterinary Medicine

Event Date: 02/09/2023
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of the Association of American Feed Control Officials (AAFCO)

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

 
Back to Top